Latest Breaking News On - Strides pharma global pte ltd - Page 1 : comparemela.com

Strides receives USFDA approval for Sucralfate oral suspension; stocks move up

Strides Pharma gains 0.76% as USFDA approves Sucralfate Oral Suspension, expanding product portfolio and market reach.

Strides pharma science ltdStrides pharma global pte ltdUnited states food drug administrationUnited states foodDrug administrationSucralfate oral suspensionOral suspensionReference listed drugChestnut ridge

USFDA grants approval to Strides Pharma for its anti-depressant drug

USFDA grants approval to Strides Pharma for its anti-depressant drug
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Us food drug administrationStrides pharma global pte ltdStrides pharma scienceFluoxetine tabsDrug administrationEli lillyObsessive compulsive disorder

Strides Pharma gets USFDA nod for antidepressant medication

The company s Singapore-based step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval for Fluoxetine Tabs (10 and 20 mg) from the US Food & Drug Administration (USFDA), the drug firm said in a regulatory filing.

Strides pharma global pte ltdUs food drug administrationStrides pharmaPharma scienceFluoxetine tabsDrug administrationEli lillyObsessive compulsive disorder

Strides Pharma gains nearly 4% on USFDA approval for oral solution to treat seizures

Strides Pharma Share Price: trides Pharma Science Ltd's (Strides) step‐down wholly-owned subsidiary received the approval for Levetiracetam Oral Solution USP, 100 mg/mL. Strides Pharma said it would manufacture the product at its facility in Bengaluru.

Tamil naduDrug administrationStrides pharma global pte ltdStrides pharma science ltdPharma science ltdLevetiracetam oral solutionStrides pharmaReference listed drugKeppra oral solutionNew yorkStrides pharma share priceTrides pharma shareTrides pharma usfda approvalTrides pharma stockStrides pharmaStrides pharma science

Strides Pharma to sell its Singapore manufacturing facility for $15 million

Additionally, as part of the transaction, Rxilient Biohub will assume the long-term lease obligation associated with the manufacturing site from Strides

Rxilient biohubStrides pharma global pte ltdStrides pharma scienceRxilient biohub pte ltdStrides pharmaPharma science limitedRxilient biohubManufacturing facility sale